Enteropathogenic E. coli bacteriophage Esc-CHP-2 and use thereof for inhibiting proliferation of enteropathogenic E. coli
US10265354B2 · kind B2 · utility
3Cited by
4References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 28, 2015 |
| Grant date | Apr 23, 2019 |
| Priority date | — |
| Expiry date | Dec 28, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2795/10132
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a Myoviridae bacteriophage Esc-CHP-2 that is isolated from the nature and can kill specifically enteropathogenic E. coli strains, which has a genome represented by the nucleotide sequence of SEQ. ID. NO: 1 (Accession NO: KCTC 12661BP), and a method for preventing and treating the infections of enteropathogenic E. coli using the composition comprising said bacteriophage as an active ingredient.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.